MDMA

Pioneering Psychedelic Researcher Once Again Paves the Way with Historic Psilocybin Study for End of Life Patients
MAPS Announces Findings from Phase 2 MDMA Clinical Trials for PTSD
Biden RAVE Act Legislation From 2003 Continues to Impede Risk Reduction Efforts
Therapists See Benefits and Risks in Psychedelic Therapy During Covid-19 Crisis